SYENA Trademark
Trademark Overview
On Wednesday, February 1, 2023, a trademark application was filed for SYENA with the United States Patent and Trademark Office. The USPTO has given the SYENA trademark a serial number of 97776708. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, July 2, 2024. This trademark is owned by Syena Inc.. The SYENA trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical products for cell therapy; cell therapy products, namely cell therapy products in the nature of cells for use in oncology, autoimmune, and inflammatory diseases.
scientific research and development; research and development in the pharmaceutical and biotechnology fields; research and development of technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; testing, inspection, research, and development of pharmaceutical preparations for gene therapy; scientific research and development of a hypoimmunogenic cell for purposes of providing cell therapy; research and development of technology in the field of cell therapy; testing, inspection, research, and development of pharmaceutical preparations for cell therapy
General Information
| Serial Number | 97776708 |
| Word Mark | SYENA |
| Filing Date | Wednesday, February 1, 2023 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, July 2, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 7, 2024 |
Trademark Statements
| Goods and Services | Pharmaceutical products for cell therapy; cell therapy products, namely cell therapy products in the nature of cells for use in oncology, autoimmune, and inflammatory diseases. |
| Goods and Services | scientific research and development; research and development in the pharmaceutical and biotechnology fields; research and development of technology in the field of gene therapy, genome writing, genome engineering, engineered HSV vector; testing, inspection, research, and development of pharmaceutical preparations for gene therapy; scientific research and development of a hypoimmunogenic cell for purposes of providing cell therapy; research and development of technology in the field of cell therapy; testing, inspection, research, and development of pharmaceutical preparations for cell therapy |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 21, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, February 21, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Syena Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
| Party Name | Syena Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Diego, CA 92121 |
Trademark Events
| Event Date | Event Description |
| Tuesday, February 7, 2023 | NEW APPLICATION ENTERED |
| Tuesday, February 21, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, October 30, 2023 | ASSIGNED TO EXAMINER |
| Monday, October 30, 2023 | NON-FINAL ACTION WRITTEN |
| Monday, October 30, 2023 | NON-FINAL ACTION E-MAILED |
| Monday, October 30, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Thursday, November 16, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, November 16, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, November 16, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, December 15, 2023 | FINAL REFUSAL WRITTEN |
| Friday, December 15, 2023 | FINAL REFUSAL E-MAILED |
| Friday, December 15, 2023 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Tuesday, March 5, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, March 5, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, March 5, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Thursday, April 4, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 17, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 7, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 7, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 2, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Friday, December 20, 2024 | SOU TEAS EXTENSION RECEIVED |
